Activation of corticotropin-releasing factor 1 receptor: Insights from molecular dynamics simulations

Journal of Physical Chemistry B

Volumn 119, Issue 7, 2015, Pages 2806-2817

  Singh, Rajesh ^a   Ahalawat, Navjeet ^a   Murarka, Rajesh K ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL MEMBRANES; CHEMICAL ACTIVATION; CRYSTAL STRUCTURE; ENZYME ACTIVITY; PROTEINS;

ACCELERATED MOLECULAR DYNAMICS; CORTICOTROPIN-RELEASING FACTORS; G PROTEIN COUPLED RECEPTORS; IRRITABLE BOWEL SYNDROMES; MEMBRANE-BOUND PROTEINS; MOLECULAR DYNAMICS SIMULATIONS; STRUCTURAL REARRANGEMENT; THERAPEUTIC INTERVENTION;

MOLECULAR DYNAMICS;

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

CHEMISTRY; MOLECULAR DYNAMICS; PRINCIPAL COMPONENT ANALYSIS;

MOLECULAR DYNAMICS SIMULATION; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 84923337570     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp509814n     Document Type: Article

References (77)

1. Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J. Seven-transmembrane receptors Nat. Rev. Mol. Cell Biol. 2002, 3 (9) 639-650
2. Rosenbaum, D. M.; Rasmussen, S. G.; Kobilka, B. K. The structure and function of G-protein-coupled receptors Nature 2009, 459 (7245) 356-363
3. Vaidehi, N.; Pease, J. E.; Horuk, R. Modeling Small Molecule-Compound Binding to G-Protein-Coupled Receptors Methods Enzymol. 2009, 460, 263-288
4. Altenbach, C.; Kusnetzow, A. K.; Ernst, O. P.; Hofmann, K. P.; Hubbell, W. L. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (21) 7439-7444
5. Liu, J. J.; Horst, R.; Katritch, V.; Stevens, R. C.; Wüthrich, K. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR Science 2012, 335 (6072) 1106-1110
6. Yao, X.; Parnot, C.; Deupi, X.; Ratnala, V. R.; Swaminath, G.; Farrens, D.; Kobilka, B. Coupling ligand structure to specific conformational switches in the β2-adrenoceptor Nat. Chem. Biol. 2006, 2 (8) 417-422
7. Hoare, S. R.; Fleck, B. A.; Gross, R. S.; Crowe, P. D.; Williams, J. P.; Grigoriadis, D. E. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation Mol. Pharmacol. 2008, 73 (5) 1371-1380
8. Kobilka, B. K.; Deupi, X. Conformational complexity of G-protein-coupled receptors Trends Pharmacol. Sci. 2007, 28 (8) 397-406
9. 2-adrenergic G protein coupled receptor Science 2007, 318 (5854) 1258-1265
10. Katritch, V.; Cherezov, V.; Stevens, R. C. Structure-function of the G protein-coupled receptor superfamily Annu. Rev. Pharmacol. Toxicol. 2013, 53, 531-556
11. 2-adrenoceptor Nature 2011, 469 (7329) 175-180
12. Li, J.; Jonsson, A. L.; Beuming, T.; Shelley, J. C.; Voth, G. A. Ligand-Dependent Activation and Deactivation of the Human Adenosine A2A Receptor J. Am. Chem. Soc. 2013, 135 (23) 8749-8759
13. Miao, Y.; Nichols, S. E.; Gasper, P. M.; Metzger, V. T.; McCammon, J. A. Activation and dynamic network of the M2 muscarinic receptor Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (27) 10982-10987
14. 2-Adrenergic Receptor Activation Cell 2013, 152 (3) 532-542
15. 2 adrenergic receptor-Gs protein complex Nature 2011, 477 (7366) 549-555
16. Dror, R. O.; Arlow, D. H.; Maragakis, P.; Mildorf, T. J.; Pan, A. C.; Xu, H.; Borhani, D. W.; Shaw, D. E. Activation mechanism of the β2-adrenergic receptor Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (46) 18684-18689
17. Dror, R. O.; Green, H. F.; Valant, C.; Borhani, D. W.; Valcourt, J. R.; Pan, A. C.; Arlow, D. H.; Canals, M.; Lane, J. R.; Rahmani, R. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs Nature 2013, 503 (7475) 295-299
18. Kohlhoff, K. J.; Shukla, D.; Lawrenz, M.; Bowman, G. R.; Konerding, D. E.; Belov, D.; Altman, R. B.; Pande, V. S. Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways Nat. Chem. 2014, 6 (1) 15-21
19. Manglik, A.; Kobilka, B. The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin Curr. Opin. Cell Biol. 2014, 27, 136-143
20. Sobhia, M. E.; Singh, R.; Kare, P.; Chavan, S. Rational design of CCR2 antagonists: a survey of computational studies Expert Opin. Drug Discovery 2010, 5 (6) 543-557
21. Singh, R.; Sobhia, M. E. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: Human CCR2 receptor J. Biomol. Struct. Dyn. 2013, 31 (7) 694-715
22. Niesen, M. J.; Bhattacharya, S.; Vaidehi, N. The role of conformational ensembles in ligand recognition in G-protein coupled receptors J. Am. Chem. Soc. 2011, 133 (33) 13197-13204
23. Kim, T. H.; Chung, K. Y.; Manglik, A.; Hansen, A. L.; Dror, R. O.; Mildorf, T. J.; Shaw, D. E.; Kobilka, B. K.; Prosser, R. S. The role of ligands on the equilibria between functional states of a G protein-coupled receptor J. Am. Chem. Soc. 2013, 135 (25) 9465-9474
24. Costanzi, S. Modeling G protein-coupled receptors and their interactions with ligands Curr. Opin. Struct. Biol. 2013, 23 (2) 185-190
25. Venkatakrishnan, A.; Deupi, X.; Lebon, G.; Tate, C. G.; Schertler, G. F.; Babu, M. M. Molecular signatures of G-protein-coupled receptors Nature 2013, 494 (7436) 185-194
26. 2 adrenergic receptor Nature 2011, 477 (7366) 611-615
27. Wootten, D.; Christopoulos, A.; Sexton, P. M. Emerging paradigms in GPCR allostery: implications for drug discovery Nat. Rev. Drug Discovery 2013, 12 (8) 630-644
28. 2 adrenoceptor complex Nature 2011, 469 (7329) 236-240
29. Elgeti, M.; Rose, A. S.; Bartl, F. J.; Hildebrand, P. W.; Hofmann, K.-P.; Heck, M. Precision vs Flexibility in GPCR signaling J. Am. Chem. Soc. 2013, 135 (33) 12305-12312
30. Hollenstein, K.; de Graaf, C.; Bortolato, A.; Wang, M.-W.; Marshall, F. H.; Stevens, R. C. Insights into the structure of class B GPCRs Trends Pharmacol. Sci. 2014, 35 (1) 12-22
31. Poyner, D. R.; Hay, D. L. Secretin family (Class B) G protein-coupled receptors-from molecular to clinical perspectives Br. J. Pharmacol. 2012, 166 (1) 1-3
32. Sloop, K. W.; Willard, F. S.; Brenner, M. B.; Ficorilli, J.; Valasek, K.; Showalter, A. D.; Farb, T. B.; Cao, J. X.; Cox, A. L.; Michael, M. D. Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets Diabetes 2010, 59 (12) 3099-3107
33. Hoare, S. R. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors Drug Discovery Today 2005, 10 (6) 417-427
34. Siu, F. Y.; Stevens, R. C. RAMP-ing up class-B GPCR ECD structural coverage Structure 2010, 18 (9) 1067-1068
35. Dong, M.; Koole, C.; Wootten, D.; Sexton, P.; Miller, L. Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs Br. J. Pharmacol. 2014, 171 (5) 1085-1101
36. Siu, F. Y.; He, M.; de Graaf, C.; Han, G. W.; Yang, D.; Zhang, Z.; Zhou, C.; Xu, Q.; Wacker, D.; Joseph, J. S. Structure of the human glucagon class B G-protein-coupled receptor Nature 2013, 499, 444-449
37. Hollenstein, K.; Kean, J.; Bortolato, A.; Cheng, R. K.; Doré, A. S.; Jazayeri, A.; Cooke, R. M.; Weir, M.; Marshall, F. H. Structure of class B GPCR corticotropin-releasing factor receptor 1 Nature 2013, 499, 438-443
38. Hemley, C.; McCluskey, A.; Keller, P. Corticotropin releasing hormone-a GPCR drug target Curr. Drug Targets 2007, 8 (1) 105-115
39. Bortolato, A.; Doré, A. S.; Hollenstein, K.; Tehan, B. G.; Mason, J. S.; Marshall, F. H. Structure of Class B GPCRs: New Horizons for Drug Discovery Br. J. Pharmacol. 2014, 171, 3132-3145
40. Trzaskowski, B.; Latek, D.; Yuan, S.; Ghoshdastider, U.; Debinski, A.; Filipek, S. Action of molecular switches in GPCRs-theoretical and experimental studies Curr. Med. Chem. 2012, 19 (8) 1090-1109
41. Hamelberg, D.; Mongan, J.; McCammon, J. A. Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules J. Chem. Phys. 2004, 120, 11919-11929
42. Pierce, L. C.; Salomon-Ferrer, R.; Augusto F. de Oliveira, C.; McCammon, J. A.; Walker, R. C. Routine access to millisecond time scale events with accelerated molecular dynamics J. Chem. Theory Comput. 2012, 8 (9) 2997-3002
43. Eswar, N.; Eramian, D.; Webb, B.; Shen, M.-Y.; Sali, A. Protein structure modeling with MODELLER Methods Mol. Biol. 2008, 426, 145-159
44. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 1983, 79 (2) 926-935
45. Phillips, J. C.; Braun, R.; Wang, W.; Gumbart, J.; Tajkhorshid, E.; Villa, E.; Chipot, C.; Skeel, R. D.; Kale, L.; Schulten, K. Scalable molecular dynamics with NAMD J. Comput. Chem. 2005, 26 (16) 1781-1802
46. Wang, Y.; Harrison, C. B.; Schulten, K.; McCammon, J. A. Implementation of accelerated molecular dynamics in NAMD Comput. Sci. Discovery 2011, 4 (1) 015002
47. MacKerell, A. D.; Bashford, D.; Bellott, M.; Dunbrack, R.; Evanseck, J.; Field, M. J.; Fischer, S.; Gao, J.; Guo, H.; Ha, S. All-atom empirical potential for molecular modeling and dynamics studies of proteins J. Phys. Chem. B 1998, 102 (18) 3586-3616
48. MacKerell, A. D.; Feig, M.; Brooks, C. L. Improved treatment of the protein backbone in empirical force fields J. Am. Chem. Soc. 2004, 126 (3) 698-699
49. Klauda, J. B.; Venable, R. M.; Freites, J. A.; OâConnor, J. W.; Tobias, D. J.; Mondragon-Ramirez, C.; Vorobyov, I.; MacKerell, A. D., Jr; Pastor, R. W. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types J. Chem. Phys. B 2010, 114 (23) 7830-7843
50. Vanommeslaeghe, K.; Hatcher, E.; Acharya, C.; Kundu, S.; Zhong, S.; Shim, J.; Darian, E.; Guvench, O.; Lopes, P.; Vorobyov, I. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields J. Comput. Chem. 2010, 31 (4) 671-690
51. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A smooth particle mesh Ewald method J. Chem. Phys. 1995, 103 (19) 8577-8593
52. Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H. J. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 1977, 23 (3) 327-341
53. Miao, Y.; Nichols, S. E.; McCammon, J. A. Free energy landscape of G-protein coupled receptors, explored by accelerated molecular dynamics Phys. Chem. Chem. Phys. 2014, 16 (14) 6398-6406
54. Pronk, S.; Páll, S.; Schulz, R.; Larsson, P.; Bjelkmar, P.; Apostolov, R.; Shirts, M. R.; Smith, J. C.; Kasson, P. M.; van der Spoel, D. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit Bioinformatics 2013, 29 (7) 845-854
55. Bhattacharya, S.; Vaidehi, N. Differences in Allosteric Communication Pipelines in the Inactive and Active States of a GPCR Biophys. J. 2014, 107 (2) 422-434
56. Eargle, J.; Luthey-Schulten, Z. NetworkView: 3D display and analysis of protein·RNA interaction networks Bioinformatics 2012, 28 (22) 3000-3001
57. Sethi, A.; Eargle, J.; Black, A. A.; Luthey-Schulten, Z. Dynamical networks in tRNA: protein complexes Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (16) 6620-6625
58. Humphrey, W.; Dalke, A.; Schulten, K. VMD: visual molecular dynamics J. Mol. Graph. 1996, 14 (1) 33-38
59. Kruse, A. C.; Hu, J.; Pan, A. C.; Arlow, D. H.; Rosenbaum, D. M.; Rosemond, E.; Green, H. F.; Liu, T.; Chae, P. S.; Dror, R. O. Structure and dynamics of the M3 muscarinic acetylcholine receptor Nature 2012, 482 (7386) 552-556
60. Heller, R. S.; Kieffer, T. J.; Habener, J. F. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling Biochem. Biophys. Res. Commun. 1996, 223 (3) 624-632
61. Hoare, S. R.; Brown, B. T.; Santos, M. A.; Malany, S.; Betz, S. F.; Grigoriadis, D. E. Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptor Biochem. Pharmacol. 2006, 72 (2) 244-255
62. Wootten, D.; Simms, J.; Miller, L. J.; Christopoulos, A.; Sexton, P. M. Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family BG protein-coupled receptor conformations Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (13) 5211-5216
63. Park, J. H.; Scheerer, P.; Hofmann, K. P.; Choe, H.-W.; Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin Nature 2008, 454 (7201) 183-187
64. Standfuss, J.; Edwards, P. C.; D’Antona, A.; Fransen, M.; Xie, G.; Oprian, D. D.; Schertler, G. F. The structural basis of agonist-induced activation in constitutively active rhodopsin Nature 2011, 471 (7340) 656-660
65. Couvineau, A.; Lacapère, J.-J.; Tan, Y.-V.; Rouyer-Fessard, C.; Nicole, P.; Laburthe, M. Identification of cytoplasmic domains of HVPAC1 receptor required for activation of adenylyl cyclase crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors J. Biol. Chem. 2003, 278 (27) 24759-24766
66. Lee, N. H.; Geoghagen, N.; Cheng, E.; Cline, R. T.; Fraser, C. M. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-XX-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors Mol. Pharmacol. 1996, 50 (1) 140-148
67. Punn, A.; Chen, J.; Delidaki, M.; Tang, J.; Liapakis, G.; Lehnert, H.; Levine, M. A.; Grammatopoulos, D. K. Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptor J. Biol. Chem. 2012, 287 (12) 8974-8985
68. Coin, I.; Katritch, V.; Sun, T.; Xiang, Z.; Siu, F. Y.; Beyermann, M.; Stevens, R. C.; Wang, L. Genetically Encoded Chemical Probes in Cells Reveal the Binding Path of Urocortin-I to CRF Class B GPCR Cell 2013, 155 (6) 1258-1269
69. Spyridaki, K.; Matsoukas, M.-T.; Cordomi, A.; Gkountelias, K.; Papadokostaki, M.; Mavromoustakos, T.; Logothetis, D. E.; Margioris, A. N.; Pardo, L.; Liapakis, G. Structural-Functional Analysis of the Third Transmembrane Domain of the CRF1 Receptor: Role in Activation and Allosteric Antagonism J. Biol. Chem. 2014, 289 (27) 18966-18977
70. Chugunov, A. O.; Simms, J.; Poyner, D. R.; Dehouck, Y.; Rooman, M.; Gilis, D.; Langer, I. Evidence that interaction between conserved residues in transmembrane helices 2, 3, and 7 are crucial for human VPAC1 receptor activation Mol. Pharmacol. 2010, 78 (3) 394-401
71. Gaudin, P.; Maoret, J.-J.; Couvineau, A.; Rouyer-Fessard, C.; Laburthe, M. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors J. Biol. Chem. 1998, 273 (9) 4990-4996
72. Schipani, E.; Langman, C.; Parfitt, A.; Jensen, G.; Kikuchi, S.; Kooh, S.; Cole, W.; Jüppner, H. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia N. Engl. J. Med. 1996, 335 (10) 708-714
73. Conner, A. C.; Hay, D. L.; Simms, J.; Howitt, S. G.; Schindler, M.; Smith, D. M.; Wheatley, M.; Poyner, D. R. A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors Mol. Pharmacol. 2005, 67 (1) 20-31
74. Durrant, J. D.; de Oliveira, C. A. F.; McCammon, J. A. POVME: an algorithm for measuring binding-pocket volumes J. Mol. Graph. Model. 2011, 29 (5) 773-776
75. Durrant, J. D.; Votapka, L.; Sørensen, J.; Amaro, R. E. POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics J. Chem. Theory Comput. 2014, 10 (11) 5047-5056
76. Ganguli, S. C.; Park, C.-G.; Holtmann, M. H.; Hadac, E. M.; Kenakin, T. P.; Miller, L. J. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis J. Pharmacol. Exp. Ther. 1998, 286 (2) 593-598
77. Rovati, G. E.; Capra, V.; Neubig, R. R. The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state Mol. Pharmacol. 2007, 71 (4) 959-964